This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Pharma Corporation. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hirakata, JP (2003)
- Tokyo, JP (2006)
Company Filing History:
Years Active: 2003-2006
Title: Tadahiro Takemoto: Innovator in Medicinal Chemistry
Introduction
Tadahiro Takemoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on hydroxamic acid derivatives. With a total of 2 patents, his research focuses on developing new medicinal products that can have a substantial impact on healthcare.
Latest Patents
One of his latest patents is titled "Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products." This invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More specifically, it addresses the use of this derivative as an inhibitor of lipopolysaccharides (LPS). Additionally, the patent discusses a novel intermediate compound that is useful for synthesizing this sulfonic acid derivative of hydroxamic acid. Another significant patent is "Hydroxamic acid derivatives and medicinal utilization thereof," which further explores the medicinal applications of these compounds.
Career Highlights
Takahiro Takemoto is associated with Mitsubishi Pharma Corporation, where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that can address various medical conditions.
Collaborations
Throughout his career, Takemoto has collaborated with notable colleagues, including Kazuhiro Maeda and Tomokazu Gotou. These collaborations have enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Tadahiro Takemoto is a distinguished inventor whose work in medicinal chemistry has led to valuable innovations. His patents reflect a commitment to advancing healthcare through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile